January 15, 2020
Health Canada has issued a No Objection Letter in response to IntelGenx’s amended application for its ongoing trial in patients...
January 13, 2020
IntelGenx confirmed that its cannabis-infused oral film, VersaFilm, is on track to be released commercially in Q1 2020.
October 9, 2019
The Data Safety Monitoring Board completed its analysis of the company's Montelukast VersaFilm Phase 2a clinical trial of Alzheimer's Disease.
September 4, 2019
One pharmaceutical company is giving consumers the chance to experience the effects of cannabis in a new form: oral strips.